Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic and Pharmacodynamic Study of Calciumfolinat in Colon Cancer
NCT02959541Unknown
- Sponsor
- Region Västra Götaland
- Start
- Sep 2016
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of folinic acid in colon cancer (3 arms), sponsored by Region Västra Götaland. Primary endpoints: [6R] 5,10-methylene-tetrahydrofolate concentration at Day 1, 5-formyl-tetrahydrofolate concentration at Day 1 and 2 more. Status: unknown.
02
Drugs
folinic acid
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02959541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02959541.